PFS
TXG icon

Prospera Financial Services’s 10x Genomics TXG Stock Holding History

Prospera Financial Services’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-22,511
Closed -$1.26M – 1080
2023
Q1 		$1.26M Buy
+22,511
New +$1.05M 0.05% 358
2022
Q3 		– Sell
-137
Closed -$6K – 1538
2022
Q2 		$6K Sell
137
-84
-38% -$4.36K ﹤0.01% 1441
2022
Q1 		$17K Buy
+221
New +$19.3K ﹤0.01% 1812

Other funds holding TXG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
SIM
SRS Investment Management New York $9.47B AUM 60.12% 1-Year Est. Return

Prospera Financial Services's TXG Position: Q2 2023 in Review

Prospera Financial Services sold out of 10x Genomics (TXG) in Q2 2023, closing a stake of 22,511 shares — an estimated $1.26M sold.

Prospera Financial Services first reported a position in TXG in Q1 2022 and held it in 3 quarters. The position peaked at $1.26M in Q1 2023. 274 funds tracked by Wall St. Rank hold TXG as of Q2 2023.

  • Prospera Financial Services reported no remaining 10x Genomics position as of Q2 2023 after selling out during the quarter.
  • Prospera Financial Services sold 22,511 10x Genomics shares in Q2 2023, an estimated $1.26M.
  • Prospera Financial Services first reported a position in 10x Genomics in Q1 2022 and held it in 3 quarters.
  • Prospera Financial Services's 10x Genomics position peaked at $1.26M in Q1 2023.
  • 274 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2023.

Based on Prospera Financial Services's 13F filing for Q2 2023, filed 8 Aug 2023.